Jul 4, 2008
Amgen Diminished Shares Look to `Savior' With Osteoporosis Drug Denosumab
Amgen Inc. 's experimental osteoporosis drug may become the top remedy for the bone- thinning disorder, gaining about half of an $8 billion annual market and reviving shares.
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Amgen's help now problem for some | Aug '08 | LadyIsREAL | 2 |
| Biz Buzz: Business briefs for Thursday, July 31... | Jul '08 | Madeline McCann | 1 |
| Is Amgen Hiring? | Jul '08 | The mex | 2 |
| EU Panel Backs Curbing Use Of Anemia Drugs In C... | Jun '08 | gdpawel | 1 |
| Simi Valley man gets two years for embezzling f... | May '08 | love animals | 1 |
| FDA panel gives surprise OK to Amgen and J&J (from Mar '08) | Mar '08 | Treat Cancer | 3 |
| Limits proposed for anemia drugs (from Mar '08) | Mar '08 | Dr Bendover | 4 |
